XML 20 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:
 6 Months Ended
Sep. 30, 2022
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:  
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY: EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:
 
Earnings (Loss) Per Share
 
A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts):
 
For the three months endedFor the six months ended
September 30,September 30,
2022202120222021
Basic earnings (loss) per share:
Net earnings (loss)$(30,436)$(6,431)$(57,654)$10,934 
Basic weighted-average shares outstanding67,096 68,042 67,750 68,185 
Basic earnings (loss) per share$(0.45)$(0.09)$(0.85)$0.16 
Diluted earnings (loss) per share:
Basic weighted-average shares outstanding67,096 68,042 67,750 68,185 
Dilutive effect of common stock options and restricted stock as computed under the treasury stock method (1)— — — 1,288 
Diluted weighted-average shares outstanding67,096 68,042 67,750 69,473 
Diluted earnings (loss) per share$(0.45)$(0.09)$(0.85)$0.16 

(1) The number of common stock options and restricted stock units as computed under the treasury stock method that would have otherwise been dilutive but are excluded from the table above because their effect would have been anti-dilutive due to the net loss position of the Company was 0.5 million and 1.3 million in the three months ended September 30, 2022 and 2021, respectively, and 0.6 million in the six months ended September 30, 2022.

Restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted earnings (loss) per share because their effect would have been anti-dilutive (other than due to the net loss position of the Company) are shown below (shares in thousands):
 
For the three months endedFor the six months ended
September 30,September 30,
2022202120222021
Number of shares underlying restricted stock units5,919 981 3,289 766 
 
Stockholders’ Equity

Under the modified common stock repurchase program, the Company may purchase up to $1.0 billion of its common stock through the period ending December 31, 2022. During the six months ended September 30, 2022, the Company repurchased 3.8 million shares of its common stock for $100.1 million under the stock repurchase program.  Through September 30, 2022, the Company had repurchased a total of 33.4 million shares of its stock for $832.3 million under the stock repurchase program, leaving remaining capacity of $167.7 million.
 
Accumulated other comprehensive income balances of $1.9 million and $5.7 million at September 30, 2022 and March 31, 2022, respectively, reflect accumulated foreign currency translation adjustments.